EdgarLookup

IOVANCE BIOTHERAPEUTICS, INC. — SC 13G/A Filings

51 SC 13G/A filings on record

This page lists all SC 13G/A filings submitted to the SEC by IOVANCE BIOTHERAPEUTICS, INC. (IOVA), sorted by most recent first. Each row links to the full filing on EdgarLookup. IOVANCE BIOTHERAPEUTICS, INC. has filed 51 SC 13G/A documents with the SEC since 2008. To view all SEC filings by IOVANCE BIOTHERAPEUTICS, INC., see the full filings list.

Overview All Filings Financials Insiders
All 10-K 10-K/A 10-Q 10-Q/A 144 3 3/A 4 4/A 424B3 424B5 5 8-A12B 8-A12B/A 8-A12G 8-K 8-K/A ARS CERTNAS CORRESP CT ORDER D DEF 14A DEF 14C DEFA14A EFFECT NT 10-K NT 10-Q POS AM PRE 14A PRE 14C PRER14A S-1 S-1/A S-3 S-3/A S-3ASR S-3MEF S-8 S-8 POS SB-2 SC 13D SC 13D/A SC 13G SC 13G/A SC 14F1 SCHEDULE 13G/A UPLOAD
Form Description Accession Number Filed Period
SC 13G/A SC 13G/A 0001193125-24-258737 Nov 14, 2024
SC 13G/A SC 13G/A 0001193125-24-036330 Feb 14, 2024
SC 13G/A IOVANCE BIOTHERAPEUTICS, INC. 0000902664-24-001524 Feb 14, 2024
SC 13G/A SCHEDULE 13G/A 0001104659-24-021231 Feb 13, 2024
SC 13G/A SC 13G/A 0001193125-24-030378 Feb 9, 2024
SC 13G/A 0001086364-24-004378 Jan 26, 2024
SC 13G/A SC 13G/A 0001193125-23-038730 Feb 14, 2023
SC 13G/A IOVANCE BIOTHERAPEUTICS, INC. 0000902664-23-001668 Feb 14, 2023
SC 13G/A SCHEDULE 13G/A 0001104659-23-016235 Feb 9, 2023
SC 13G/A SEC SCHEDULE 13G 0000846087-23-000244 Feb 6, 2023
SC 13G/A 0000834237-22-008762 Feb 24, 2022
SC 13G/A SC 13G/A 0001193125-22-041519 Feb 14, 2022
SC 13G/A 0000080255-22-002106 Feb 14, 2022
SC 13G/A IOVANCE BIOTHERAPEUTICS, INC. 0000902664-22-001520 Feb 11, 2022
SC 13G/A SCHEDULE 13G/A 0001104659-22-017852 Feb 10, 2022
SC 13G/A SC 13G/A 0001193125-21-044711 Feb 16, 2021
SC 13G/A 0000080255-21-001217 Feb 16, 2021
SC 13G/A IOVANCE BIOTHERAPEUTICS, INC. 0000902664-21-001230 Feb 12, 2021
SC 13G/A SCHEDULE 13G/A 0001104659-21-018388 Feb 10, 2021
SC 13G/A 0000834237-21-003984 Jan 29, 2021
SC 13G/A IOVANCE BIOTHERAPEUTICS, INC. 0000902664-20-001309 Feb 24, 2020
SC 13G/A SC 13G/A 0001193125-20-038113 Feb 14, 2020
SC 13G/A IOVANCE BIOTHERAPEUTICS, INC. 0000902664-20-001115 Feb 14, 2020
SC 13G/A 0000834237-20-005360 Feb 5, 2020
SC 13G/A IOVANCE BIOTHERAPEUTICS, INC. 0000902664-19-001014 Feb 14, 2019
SC 13G/A 0000919574-19-001204 Feb 13, 2019
SC 13G/A SCHEDULE 13G HOLDINGS REPORT AMENDMENT 0001172661-19-000439 Feb 13, 2019
SC 13G/A 0000215457-19-004040 Feb 4, 2019
SC 13G/A AMENDMENT NO. 3 TO SCHEDULE 13G 0001193125-18-045302 Feb 14, 2018
SC 13G/A 13G/A 0001172661-18-000529 Feb 13, 2018
SC 13G/A 0000315066-18-001326 Feb 13, 2018
SC 13G/A IOVANCE BIOTHERAPEUTICS, INC. 0000902664-18-000872 Feb 12, 2018
SC 13G/A 0001493152-17-008420 Aug 3, 2017
SC 13G/A 0000215457-17-003128 May 9, 2017
SC 13G/A 0001493152-17-001705 Feb 16, 2017
SC 13G/A SC 13G/A 0001019056-17-000193 Feb 14, 2017
SC 13G/A 0000315066-17-001812 Feb 14, 2017
SC 13G/A 0000919574-17-001233 Feb 10, 2017
SC 13G/A LION BIOTECHNOLOGIES, INC. 0000902664-17-000956 Feb 9, 2017
SC 13G/A 0000353480-17-001166 Jan 25, 2017
SC 13G/A 0001085256-16-000031 Nov 3, 2016
SC 13G/A SC 13G/A 0001019056-16-001120 Feb 16, 2016
SC 13G/A 0000315066-16-005258 Feb 12, 2016
SC 13G/A AMENDMENT NO. 5 0001019687-16-005094 Feb 9, 2016
SC 13G/A NONE 0001140361-15-021054 May 20, 2015
SC 13G/A 0000315066-15-002035 Feb 13, 2015
SC 13G/A SCHEDULE 13D AMENDMENT 0001019687-15-000547 Feb 11, 2015
SC 13G/A AMENDMENT TO SCHEDULE 13G 0001213900-14-000725 Feb 10, 2014
SC 13G/A SCHEDULE 13G AMENDMENT 0001019687-12-002084 Jun 8, 2012
SC 13G/A NONE 0001140361-12-019005 Apr 4, 2012